Presentation is loading. Please wait.

Presentation is loading. Please wait.

Nat. Rev. Cardiol. doi: /nrcardio

Published byΓώργος Μιχαηλίδης Modified over 5 years ago

Similar presentations

Presentation on theme: "Nat. Rev. Cardiol. doi: /nrcardio"— Presentation transcript:

1 Nat. Rev. Cardiol. doi:10.1038/nrcardio.2017.108
Figure 1 Mortality in patients undergoing percutaneous coronary intervention Figure 1 | Mortality in patients undergoing percutaneous coronary intervention. Hazard ratio for mortality after percutaneous coronary intervention (median follow-up 2.1 years) according to BMI. Reproduced from Powell, B. D. et al. Association of body mass index with outcome after percutaneous coronary intervention. Am. J. Cardiol. 91, 472–476 (2003), with permission from Elsevier. Reproduced from Powell, B. D. et al. Association of body mass index with outcome after percutaneous coronary intervention. Am. J. Cardiol. 91,472–476 (2003), with permission from Elsevier. Lavie, C. J. et al. (2017) Management of cardiovascular diseases in patients with obesity Nat. Rev. Cardiol. doi: /nrcardio

Download ppt "Nat. Rev. Cardiol. doi: /nrcardio"

Similar presentations

The relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: a report from APPROACH by Antigone.

The relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: a report from APPROACH by Antigone.
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Figure 10 Assessment of myocardial fibrosis

Figure 10 Assessment of myocardial fibrosis
Figure 5 BMI and cardiorespiratory fitness levels

Figure 5 BMI and cardiorespiratory fitness levels
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Figure 4 Pharmacodynamic comparison of crushed versus integral

Figure 4 Pharmacodynamic comparison of crushed versus integral
Figure 4 BMI and mortality in patients with heart failure

Figure 4 BMI and mortality in patients with heart failure
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Figure 5 Two approaches to therapeutic genome editing

Figure 5 Two approaches to therapeutic genome editing
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Figure 3 Global rates of sodium, fruit, and vegetable intake

Figure 3 Global rates of sodium, fruit, and vegetable intake
Figure 1 Anatomy of the femoral artery

Figure 1 Anatomy of the femoral artery
Figure 3 Ischaemic outcomes in the ST-segment elevation myocardial

Figure 3 Ischaemic outcomes in the ST-segment elevation myocardial
Figure 2 Size categorization of airborne pollutants

Figure 2 Size categorization of airborne pollutants
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio

Nat. Rev. Cardiol. doi: /nrcardio
Figure 2 Three-year survival rates on the basis of body composition

Figure 2 Three-year survival rates on the basis of body composition
Figure 2 Physical activity and obesity levels by WHO-designated region and sex Figure 2 | Physical activity and obesity levels by WHO-designated region.

Figure 2 Physical activity and obesity levels by WHO-designated region and sex Figure 2 | Physical activity and obesity levels by WHO-designated region.
Figure 8 4D magnetic resonance imaging patterns

Figure 8 4D magnetic resonance imaging patterns

Similar presentations

Ads by Google